Dr. Laurie Glimcher, inspired by her father, learned that big discoveries require big risks in science. In the late 1990s, she and her postdoctoral student conducted experiments at her Harvard immunology lab that colleagues considered “crazy.” After a year of trial and error, they made a groundbreaking discovery that white blood cells could be reprogrammed, leading to new ways to treat cancer. Glimcher emphasized the importance of thinking big and aiming for significant scientific advancements. She believes that transforming scientific questions requires pursuing important and ambitious goals. Her story can be read in full on STAT+.
Source link
Opinion: STAT+: Dana-Farber CEO Laurie Glimcher has always been a trailblazer and a risk taker
